Clinical Trial Update: Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update reports phase 1/2 results for a trial evaluating sorafenib in combination with anastrozole in postmenopausal women with metastatic/recurrent breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Nexavar (Sorafenib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Breast Cancer, Stage IV Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-02-12